Professor, Radiology
UT Southwestern Medical Center
Dallas, TX
Orhan Öz, M.D., Ph.D., is Professor of Radiology and Chief of Nuclear Medicine at UT Southwestern Medical Center, and holder of the Robert W. Parkey, MD Distinguished Professorship. He also holds a secondary appointment in the Charles and Jane Pak Center for Mineral Metabolism and Clinical Research, in which he holds the Wechun Pak Professorship in Bone Biophysics. Additionally, Dr. Öz serves as Medical Director of Nuclear Medicine at Parkland Memorial Hospital, and directs the UT Southwestern Nuclear Medicine Residency program. His clinical interests include nuclear medicine, radiology, and infection and cancer imaging, with a particular interest in molecular imaging for diagnostic, prognostic and evaluation of therapeutic responses.
Dr. Öz holds a bachelor’s degree in biology, chemistry, and mathematics from Morehouse College in Atlanta, and a master’s degree in applied mathematics from Clark Atlanta University. After receiving his medical degree and doctoral degree in biophysics from Stanford University, he completed his residency training in radiology at UT Southwestern, where he remained to receive advanced training through a fellowship program in radiology and molecular biology. He then received fellowship training in radiologic pathology at the Armed Forces Institute of Pathology, and in positron emission tomography (PET) at University of California Los Angeles medical center.
Although the majority of his time is dedicated to clinical practice, Dr. Öz is highly involved in research. His interests include molecular mechanisms of bacterial infections, in vivo imaging of infections in humans, tumor imaging, imaging methods of bone density determination, and investigating the mechanisms underlying estrogen regulation of bone mass and metabolism. His research has resulted in numerous publications throughout his career, including the publication of a single-photon emission computed tomography (SPECT) and computed tomography (CT) based scoring system to stage the severity of foot infections in people with diabetes.
Disclosure information not submitted.
Friday, April 8, 2022
9:15 AM – 10:15 AM MST